Characterizing and understanding the formation of cysteine conjugates and other by-products in a random, lysine-linked antibody drug conjugate
This study describes the characterization of conjugation sites for a random, lysine conjugated 2-iminothiolane (2-IT) based antibody-drug-conjugate synthesized from an IgG1 antibody and a duocarmycin analog-based payload-linker. Of the 80 putative lysine sites, 78 were found to be conjugated via try...
Saved in:
Main Authors: | Difei Qiu (Author), Yande Huang (Author), Naresh Chennamsetty (Author), Scott A. Miller (Author), Michael Hay (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues
by: Qun Zhou, et al.
Published: (2021) -
Interrogating heterogeneity of cysteine-engineered antibody-drug conjugates and antibody-oligonucleotide conjugates by capillary zone electrophoresis-mass spectrometry
by: Tian Xu, et al.
Published: (2023) -
Synthesis and characterization of a cysteine xyloglucan conjugate as mucoadhesive polymer
by: Mangesh Bhalekar, et al.
Published: (2013) -
Conjugation of a peptide to an antibody engineered with free cysteines dramatically improves half-life and activity
by: Raul C. Camacho, et al.
Published: (2020) -
Intra-Domain Cysteines (IDC), a New Strategy for the Development of Original Antibody Fragment-Drug Conjugates (FDCs)
by: Louis Jolivet, et al.
Published: (2022)